1.
Aygen B, Demir AM, Gümüş M, Karabay O, Kaymakoğlu S, Köksal A Şeref, et al. Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report. Turkish Journal of Gastroenterology [Internet]. 2018 Jan. 3 [cited 2026 Jan. 1];29(3):259-6. Available from: https://turkjgastroenterol.org/index.php/tjg/article/view/3248